 |
市場調査レポート
商品コード
1373859
下肢静脈瘤治療の世界市場 - 市場規模、シェア、成長分析：タイプ別、最終用途別 - 業界予測（2023年～2030年）Global Varicose Veins Treatment Market Size, Share, Growth Analysis, By Type(Endovenous Ablation, and Surgical Ligation & Stripping), By End-use(Vein clinics, hospitals) - Industry Forecast 2023-2030 |
||||||
| 下肢静脈瘤治療の世界市場 - 市場規模、シェア、成長分析：タイプ別、最終用途別 - 業界予測（2023年～2030年） |
|
出版日: 2023年10月23日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の下肢静脈瘤治療の市場規模は2021年に12億2,000万米ドル、2022年に13億米ドルとなりました。同市場は、予測期間中（2023年～2030年）に6.32%のCAGRで拡大し、2030年には21億2,000万米ドルに成長する見通しです。
世界の下肢静脈瘤治療市場は近年大きな成長を遂げており、今後も拡大が続くと予想されます。下肢静脈瘤は、主に足の静脈の腫れやねじれを特徴とする一般的な病状です。人口の高齢化、座りがちなライフスタイル、肥満、遺伝的要因などの要因が、世界の下肢静脈瘤の有病率の上昇に寄与しており、効果的な治療オプションに対する需要を牽引しています。市場では、内因性レーザー焼灼術、硬化療法、高周波焼灼術などの低侵襲手技を含むいくつかの治療法が利用可能です。これらの処置は、従来の外科的方法と比較して、痛みの軽減、回復時間の短縮、傷跡の最小化などの利点を提供します。低侵襲治療の増加採用は下肢静脈瘤治療市場の成長を煽っています。さらに、技術や医療機器の進歩により、治療成績や患者の満足度がさらに向上しています。超音波ガイド下泡沫硬化療法や非熱アブレーションなどの革新的な技術は、静脈瘤の効果的な治療において有望な結果を示しています。これらの進歩は、利用可能な治療の選択肢を広げただけでなく、患者の全体的な経験も向上させています。しかし、市場成長の可能性にもかかわらず、いくつかの課題も存在します。償還の問題や高額な治療費は、一部の患者にとって静脈瘤治療へのアクセスを制限する可能性があります。特に新興諸国では、不十分な保険適用や償還政策が経済的な障壁となる可能性があります。
下肢静脈瘤と利用可能な治療オプションに関する認識と教育の高まりが市場成長に寄与しています。一般の認識向上キャンペーン、患者教育イニシアティブ、およびさまざまなチャネルを通じた情報普及が、静脈瘤を持つ個人が適切な治療を受けることを奨励しています。
特に先進諸国における積極的な償還政策は、患者の下肢静脈瘤治療へのアクセスを容易にしています。硬化療法や静脈内焼灼療法のような処置に対する保険適用や償還支援により、これらの治療がより手頃な価格で利用しやすくなり、市場の成長を後押ししています。
当レポートは、世界の下肢静脈瘤治療市場について調査し、市場の概要とともに、タイプ別、最終用途別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。
目次
エグゼクティブサマリー
親市場分析
市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主要な市場の洞察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 動向分析
- スタートアップ分析
- 原材料分析
- イノベーションマトリックス
- パイプライン製品分析
- マクロ経済指標
- トップ投資分析
- 主な成功要因
- 競合の程度
市場力学と見通し
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制状況
- ポーター分析
世界の下肢静脈瘤治療市場、タイプ別
- 市場概要
- 静脈内アブレーション
- 外科的結紮、ストリッピング
世界の下肢静脈瘤治療市場、最終用途別
- 市場概要
- 静脈クリニック
- 病院
- および外来治療施設
世界の下肢静脈瘤治療市場、地域別
- 市場概要
- 北米
- 欧州
- アジア太平洋
- ラテンアメリカ
- 中東・アフリカ
競合情勢
- 主要企業プロファイル
- Medtronic
- AngioDynamics
- Lumenis
- Syneron Medical Ltd.
- Biolitec AG
- BTG International Ltd
- Vascular Solutions, Inc.
- Energist Group
- Eufoton
- Quanta System
- Miravas
- Vein Clinics of America
- Alna-Medical System GmbH
- Miravas SAS
- Sciton, Inc.
- Dornier MedTech GmbH
- LSO Medical
- Vascular Insights, LLC
- WONTECH Co., Ltd.
- LSO Medical SAS
Global Varicose Veins Treatment Market size was valued at USD 1.22 Billion in 2021 and is poised to grow from USD 1.3 Billion in 2022 to USD 2.12 Billion by 2030, at a CAGR of 6.32% during the forecast period (2023-2030).
The global varicose veins treatment market has experienced significant growth in recent years and is expected to continue expanding in the coming years. Varicose veins are a common medical condition characterized by swollen and twisted veins, primarily in the legs. Factors such as aging population, sedentary lifestyles, obesity, and hereditary factors contribute to the rising prevalence of varicose veins worldwide, driving the demand for effective treatment options. Several treatment modalities are available in the market, including minimally invasive procedures such as endogenous laser ablation, sclerotherapy, and radiofrequency ablation. These procedures offer advantages such as reduced pain, shorter recovery time, and minimal scarring compared to traditional surgical methods. The increasing adoption of minimally invasive treatments is fueling the growth of the varicose veins treatment market. Moreover, advancements in technology and medical devices have further improved treatment outcomes and patient satisfaction. Innovative techniques, such as ultrasound-guided foam sclerotherapy and non-thermal ablation, have shown promising results in effectively treating varicose veins. These advancements have not only expanded the treatment options available but also enhanced the overall patient experience. However, despite the market's growth potential, several challenges exist. Reimbursement issues and the high cost of treatment can limit the accessibility of varicose veins treatment for some patients. Inadequate insurance coverage and reimbursement policies may pose financial barriers, particularly in developing countries.
Top-down and bottom-up approaches were used to estimate and validate the size of the global Emergency Lighting Systems Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Varicose Veins Treatment Market Segmental Analysis
The global varicose veins treatment market is segmented on the basis of type, end-use, and region. By type, the market is segmented into Endovenous Ablation, and Surgical Ligation & Stripping. By end use, the market is segmented into vein clinics, hospitals, and ambulatory care units. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Global Varicose Veins Treatment Market Dynamics
Drivers of the Global Varicose Veins Treatment Market
Growing Awareness and Patient Education
Increased awareness and education regarding varicose veins and available treatment options have contributed to market growth. Public awareness campaigns, patient education initiatives, and information dissemination through various channels have encouraged individuals with varicose veins to seek appropriate treatment.
Favorable Reimbursement Policies
Positive reimbursement policies, particularly in developed countries, have facilitated access to varicose veins treatment for patients. Insurance coverage and reimbursement support for procedures like sclerotherapy and endovenous ablation have made these treatments more affordable and accessible, boosting market growth.
Restraints in the Global Varicose Veins Treatment Market
Regulatory Challenges
Regulatory requirements and product approval processes can pose challenges for manufacturers in the varicose veins treatment market. Obtaining regulatory approvals and complying with various regulations in different countries can be time-consuming and costly, affecting the introduction of new treatments and innovations.
Alternative Treatment Options
Alternative treatments, such as compression therapy and lifestyle modifications, may be considered by some patients as an initial or complementary approach to managing varicose veins. These non-invasive options can compete with more invasive treatment methods, potentially impacting the market growth of varicose veins treatments.
Market Trends of the Global Varicose Veins Treatment Key
Growing Emphasis on Combination Therapies
Combination therapies involving multiple treatment modalities are gaining popularity in varicose veins treatment. Combining procedures such as endovenous ablation and sclerotherapy can optimize outcomes by targeting different aspects of the venous disease, leading to improved efficacy and patient satisfaction.
Focus on Patient-Centric Approaches
There is an increasing emphasis on patient-centric care in varicose veins treatment. Healthcare providers are focusing on personalized treatment plans, patient education, and shared decision-making to ensure optimal outcomes and patient satisfaction.
Table of Contents
- Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
- Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
- Global Varicose Veins Treatment Market by Type
- Market Overview
- Endovenous Ablation
- and Surgical Ligation & Stripping
- Global Varicose Veins Treatment Market by End-use
- Market Overview
- Vein clinics
- hospitals
- and ambulatory care units
- Global Varicose Veins Treatment Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Medtronic (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- AngioDynamics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lumenis (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Syneron Medical Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Biolitec AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- BTG International Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vascular Solutions, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Energist Group (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eufoton (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Quanta System (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Miravas (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vein Clinics of America (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Alna-Medical System GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Miravas SAS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sciton, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Dornier MedTech GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LSO Medical (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Vascular Insights, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- WONTECH Co., Ltd. (South Korea)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- LSO Medical SAS (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
